308 related articles for article (PubMed ID: 11238097)
21. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.
Ash RC; Horowitz MM; Gale RP; van Bekkum DW; Casper JT; Gordon-Smith EC; Henslee PJ; Kolb HJ; Lowenberg B; Masaoka T
Bone Marrow Transplant; 1991 Jun; 7(6):443-52. PubMed ID: 1873591
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome.
Rumelhart SL; Trigg ME; Horowitz SD; Hong R
Blood; 1990 Feb; 75(4):1031-5. PubMed ID: 2302455
[TBL] [Abstract][Full Text] [Related]
24. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.
Kobayashi R; Ariga T; Nonoyama S; Kanegane H; Tsuchiya S; Morio T; Yabe H; Nagatoshi Y; Kawa K; Tabuchi K; Tsuchida M; Miyawaki T; Kato S
Br J Haematol; 2006 Nov; 135(3):362-6. PubMed ID: 17032176
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic bone marrow transplantation in children from other than HLA-identical sibling donor.
Locatelli F; Bongiorno M; Zecca M; Giani S; Giorgiani G; Guagnini R; Morandi P; Porta F; Nespoli L; Burgio GR
Bone Marrow Transplant; 1991; 7 Suppl 3():124-7. PubMed ID: 1855074
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.
Ozsahin H; Le Deist F; Benkerrou M; Cavazzana-Calvo M; Gomez L; Griscelli C; Blanche S; Fischer A
J Pediatr; 1996 Aug; 129(2):238-44. PubMed ID: 8765621
[TBL] [Abstract][Full Text] [Related]
27. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies.
Filipovich AH; Shapiro RS; Ramsay NK; Kim T; Blazar B; Kersey J; McGlave P
Blood; 1992 Jul; 80(1):270-6. PubMed ID: 1611094
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
[TBL] [Abstract][Full Text] [Related]
30. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.
Hessner MJ; Endean DJ; Casper JT; Horowitz MM; Keever-Taylor CA; Roth M; Flomenberg N; Drobyski WR
Blood; 1995 Nov; 86(10):3987-96. PubMed ID: 7579370
[TBL] [Abstract][Full Text] [Related]
31. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors.
Anasetti C; Hansen JA
Transfus Sci; 1994 Sep; 15(3):221-30. PubMed ID: 10155543
[TBL] [Abstract][Full Text] [Related]
32. Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO).
Dini G; Cancedda R; Locatelli F; Bosi A; Bandini G; Alessandrino EP; Porta F; Uderzo C; Messina C; Fagioli F; Arcese W; Marenco P; Fanin R; Falda M; Soligo D; La Nasa G; Giardini C; Pession A; Scimè R; Di Bartolomeo P; Bruno B; Garbarino L; Lamparelli T; Giorgiani G; Lanino E; Manzitti C; Bacigalupo A;
Haematologica; 2001 May; 86(5):451-6. PubMed ID: 11410406
[TBL] [Abstract][Full Text] [Related]
33. Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.
Perkins HA; Kollman C; Howe CW
Clin Transpl; 1994; ():295-301. PubMed ID: 7547550
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years.
Marks DI; Cullis JO; Ward KN; Lacey S; Syzdlo R; Hughes TP; Schwarer AP; Lutz E; Barrett AJ; Hows JM; Batchelor JR; Goldman JM
Ann Intern Med; 1993 Aug; 119(3):207-14. PubMed ID: 8391772
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.
Shaw PJ; Kan F; Woo Ahn K; Spellman SR; Aljurf M; Ayas M; Burke M; Cairo MS; Chen AR; Davies SM; Frangoul H; Gajewski J; Gale RP; Godder K; Hale GA; Heemskerk MB; Horan J; Kamani N; Kasow KA; Chan KW; Lee SJ; Leung WH; Lewis VA; Miklos D; Oudshoorn M; Petersdorf EW; Ringdén O; Sanders J; Schultz KR; Seber A; Setterholm M; Wall DA; Yu L; Pulsipher MA
Blood; 2010 Nov; 116(19):4007-15. PubMed ID: 20671124
[TBL] [Abstract][Full Text] [Related]
36. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.
Hansen JA; Gooley TA; Martin PJ; Appelbaum F; Chauncey TR; Clift RA; Petersdorf EW; Radich J; Sanders JE; Storb RF; Sullivan KM; Anasetti C
N Engl J Med; 1998 Apr; 338(14):962-8. PubMed ID: 9521984
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
Weisdorf DJ; Anasetti C; Antin JH; Kernan NA; Kollman C; Snyder D; Petersdorf E; Nelson G; McGlave P
Blood; 2002 Mar; 99(6):1971-7. PubMed ID: 11877268
[TBL] [Abstract][Full Text] [Related]
40. Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.
Giralt S; Szydlo R; Goldman JM; Veum-Stone J; Biggs JC; Herzig RH; Klein JP; McGlave PB; Schiller G; Gale RP; Rowlings PA; Horowitz MM
Blood; 2000 Jan; 95(2):410-5. PubMed ID: 10627443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]